(INNO) HERZLIYA, Israel and CALGARY, Alberta, Aug. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that further to its press release dated July 23, 2025, it will be consolidating all of its issued and...